Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Cascara Ventures is a venture capital firm founded in 2016 by Adriaan Hart de Ruijter, who brings a wealth of experience as both an entrepreneur and investor in the life sciences sector. Based in Europe, the firm specializes in early-stage investments, particularly in companies that leverage technology for prevention, therapy, and research in life sciences. Cascara Ventures has established itself as a key player in the European venture capital landscape, focusing on seed-stage investments that drive innovation in healthcare.
The firm operates as an accredited investor with the European Investment Fund, which enhances its ability to match investments on a pari passu basis. This accreditation allows Cascara Ventures to increase its commitment to a larger number of startups, thereby supporting their growth from inception through to maturity. The firm is recognized for its active management approach, ensuring that portfolio companies receive the necessary guidance and resources to navigate the complexities of regulatory and clinical development.
Cascara Ventures concentrates its investment efforts on seed-stage companies within the life sciences sector. The firm targets a diverse range of technology-driven solutions, including but not limited to vaccines, medical devices, pharmaceuticals, imaging, software, medical data, robotics, healthcare services, diagnostics, and cell therapy. This broad investment focus reflects Cascara's commitment to fostering innovation in healthcare through advanced technologies.
By emphasizing early-stage investing, Cascara Ventures aims to identify and support startups that are poised to make significant impacts in their respective fields. The firm leverages its expertise in regulatory and clinical development to actively manage its portfolio, providing strategic guidance and operational support to help companies navigate the challenges of bringing new technologies to market. This hands-on approach not only enhances the growth trajectory of portfolio companies but also aligns with Cascara's mission to drive meaningful advancements in life sciences.
Cascara Ventures collaborates with a robust network of investors and funds, enabling it to support its portfolio companies through various stages of growth. While specific details regarding the portfolio size or notable investments are not publicly available, the firm's accreditation with the European Investment Fund allows it to match investments, thereby increasing its commitment to a larger number of startups. This collaborative approach enhances the resources available to portfolio companies, facilitating their development and scaling efforts.
By focusing on early-stage investments in the life sciences sector, Cascara Ventures positions itself as a valuable partner for startups aiming to innovate in healthcare. The firm's emphasis on technology-driven solutions and active management ensures that portfolio companies receive the necessary support to thrive in a competitive landscape.
Adriaan Hart de Ruijter - Founder and Managing Partner. Adriaan has extensive experience as an entrepreneur and investor in the life sciences sector, guiding the firm’s strategic direction and investment focus.
Cascara Ventures primarily invests in seed-stage companies within the life sciences sector. The firm focuses on early-stage investments to support innovative startups as they develop their technologies and business models.
The firm specializes in the life sciences sector, targeting a wide range of areas including vaccines, medical devices, pharmaceuticals, imaging, software, medical data, robotics, healthcare services, diagnostics, and cell therapy.
While specific check sizes are not publicly disclosed, Cascara Ventures emphasizes seed-stage investments, which typically range from hundreds of thousands to a few million euros, depending on the startup's needs and growth potential.
Cascara Ventures focuses its investments across Europe, seeking to support innovative life sciences companies that leverage technology to improve healthcare outcomes.
Founders interested in pitching to Cascara Ventures should prepare a comprehensive business plan that outlines their technology, market potential, and team. The firm values early-stage companies that demonstrate a clear path to innovation in the life sciences sector.
Cascara Ventures takes an active management approach, offering strategic guidance and operational support to its portfolio companies. This includes leveraging their expertise in regulatory and clinical development to help startups navigate the complexities of bringing new technologies to market.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.